Health Care Equipment & Services

HealthEquity CEO Cutler Scott sells 4,931 shares—routine liquidity move, not a red flag—while a new CTO could boost tech‑driven drug‑utilization analytics.

Inogen insider sales reveal routine RSU vesting, not a crisis. Investors learn how executive liquidity moves reflect broader strategic shifts and future growth prospects.

Outset Medical’s new EVP’s RSU purchase signals strong executive confidence and may spark a growth push in its niche hemodialysis market.

Alignment Healthcare CFO James M. Head’s April 7 RSU sale is a routine tax‑cover move, not a confidence warning, while CEO sales and strong earnings keep investor buzz high.

Insider buying at ELHI signals CEO confidence in future growth, even amid a negative P/E. Learn how the latest purchases may indicate a buying opportunity.

HealthEquity insider sale by founder Stephen Neeleman reveals leadership shifts, potential AI-driven health‑tech growth, and investor sentiment – what it means for the stock.

Insider sell‑to‑cover activity at Sophia Genetics SA shows routine tax‑coverage, not a shift in confidence, amid growing subscription and AI‑driven genomic diagnostics.

Insider buying surge at Sophia Genetics signals strong executive confidence and potential upside in its FDA‑cleared precision‑medicine platform—investors should watch.

Insider buying spurs optimism for Sophia Genetics, a genomics‑AI firm with strong IP and strategic partners, as executives boost long‑term confidence.

VivoPower insider holdings reveal no trading activity, steady confidence in renewable growth and potential AI-driven innovation—watch for future market moves.